OLE of Phase 2b/3 Study ANAVEX2-73-AD-004
NCT04314934
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
ANAVEX2-73
Sponsor
Anavex Life Sciences Corp.
Collaborators
[object Object]
[object Object]